By Stephanie Landsman, Producer, "Squawk Box" NEW YORK ( CNBC) --While allergy sufferers pay the price for a warmer than usual winter, profits will likely bloom for pharmaceutical companies. So stop and smell the roses. This could provide a healthy boost to your portfolio. It's only March and pollen counts are setting record highs all over the Southeast. In New York City, trees are blooming several weeks ahead of schedule. "An early start to the allergy season is always good for the large pharmaceutical companies that manufacture allergy meds," said Paul Walsh, vice president of weather analytics at the Weather Channel. "This year's mild winter followed by record spring warmth is manna from heaven for these firms." (Note: The Weather Channel is owned by NBCUniversal, CNBC's corporate parent.)
| More from CNBC 'Solar Flare-Ups': Petitions Over UFOs and Weather Cuts |
Did a Tax-Budget Battle Almost Kill the US in 1812?
Hamptons 'Beach Pass Barometer': Economic Rebound Sign?